A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment.
Clinical trial NCT03605706 · UNKNOWN
Trial details
- NCT number
- NCT03605706
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-31
- Primary completion
- 2023-02-01
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.